Last Updated: June 30, 2026

MOLINDONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Molindone, and when can generic versions of Molindone launch?

Molindone is a drug marketed by Epic Pharma Llc and is included in one NDA.

The generic ingredient in MOLINDONE is molindone hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the molindone hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Molindone

A generic version of MOLINDONE was approved as molindone hydrochloride by EPIC PHARMA LLC on March 20th, 2015.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for MOLINDONE?
  • What are the global sales for MOLINDONE?
  • What is Average Wholesale Price for MOLINDONE?
Summary for MOLINDONE
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:MOLINDONE at DailyMed

US Patents and Regulatory Information for MOLINDONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Epic Pharma Llc MOLINDONE HYDROCHLORIDE molindone hydrochloride TABLET;ORAL 090453-001 Mar 20, 2015 RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Epic Pharma Llc MOLINDONE HYDROCHLORIDE molindone hydrochloride TABLET;ORAL 090453-002 Mar 20, 2015 RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Epic Pharma Llc MOLINDONE HYDROCHLORIDE molindone hydrochloride TABLET;ORAL 090453-003 Mar 20, 2015 RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.